Emotion and episodic memory in neuropsychiatric disorders

Behavioural Brain Research

Volumn 215, Issue 2, 2010, Pages 162-171

  Dere, Ekrem ^a   Pause, Bettina M ^a   Pietrowsky, Reinhard ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Amygdala; Comparative psychology; Hippocampus; Major depression; Post traumatic stress disorder; Schizophrenia

Indexed keywords

CHOLECYSTOKININ; NEUROKININ; NEUROPEPTIDE;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; EMOTION; EPISODIC MEMORY; HIPPOCAMPUS; HUMAN; INSULA; LEARNING; MAJOR DEPRESSION; MAMMAL; MENTAL DISEASE; MOOD DISORDER; NEUROIMAGING; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; STIMULUS RESPONSE;

ANIMALS; BRAIN; EMOTIONS; HUMANS; MEMORY DISORDERS; MENTAL DISORDERS; MENTAL RECALL;

EID: 77956426174     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.03.017     Document Type: Review

References (171)

1. Aggleton J.P., Saunders R.C., Vann S.D. Using hippocampal amnesia to understand the neural basis of diencephalic amnesia. Handbook of Behavioral Neuroscience, Handbook of Episodic Memory 2008, vol. 18:503-519. Elsevier, Amsterdam.
2. Airaksinen E., Larsson M., Forsell Y. Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction. J Psychiatr Res 2005, 39:207-214.
3. Airaksinen E., Larsson M., Lundberg I., Forsell Y. Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 2004, 34:83-91.
4. Airaksinen E., Wahlin A., Forsell Y., Larsson M. Low episodic memory performance as a premorbid marker of depression: evidence from a 3-year follow-up. Acta Psychiatr Scand 2007, 115:458-465.
5. Airaksinen E., Wahlin A., Larsson M., Forsell Y. Cognitive and social functioning in recovery from depression: results from a population-based three-year follow-up. J Affect Disord 2006, 96:107-110.
6. Aleman A., Hijman R., de Haan E.H., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999, 156:1358-1366.
7. Allen P.A., Kaut K.P., Lord R.G., Hall R.J., Grabbe J.W., Bowie T. An emotional mediation theory of differential age effects in episodic and semantic memories. Exp Aging Res 2005, 31:355-391.
8. Altmann E.M. Update. Evidence for temporal decay in short-term episodic memory. Trends Cogn Sci 2009, 13:279.
9. Anderson A.K., Phelps E.A. Lesions of the human amygdala emotionally salient events. Nature 2001, 411:305-309.
10. Bäckman L., Jones S., Berger A.K., Laukka E.J., Small B.J. Multiple cognitive deficits during the transition to Alzheimer's disease. J Intern Med 2004, 256:195-204.
11. Bäckman L., Small B.J. Cognitive deficits in preclinical Alzheimer's disease and vascular dementia: patterns of findings from the Kungsholmen Project. Physiol Behav 2007, 92:80-86.
12. Barch D.M. The cognitive neuroscience of schizophrenia. Annu Rev Clin Psychol 2005, 1:321-353.
13. Barch D.M., Sheline Y.I., Csernansky J.G., Snyder A.Z. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry 2003, 53:376-384.
14. Beck A.T., Clark D.M. An information processing model of anxiety: automatic and strategic processes. Behav Res Ther 1997, 35:49-58.
15. Bekker M.H., van Mens-Verhulst J. Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment. Gend Med 2007, 4(Suppl. B):S178-S193.
16. Bennett G.W., Ballard T.M., Watson C.D., Fone K.C. Effect of neuropeptides on cognitive function. Exp Gerontol 1997, 32:451-469.
17. Bierman E.J., Comijs H.C., Jonker C., Beekman A.T. Effects of anxiety versus depression on cognition in later life. Am J Geriatr Psychiatry 2005, 13:686-693.
18. Bond A.H. Representing episodic memory in a system-level model of the brain. Neurocomputing 2005, 65:261-273.
19. Born J., Pietrowsky R., Fehm H.L. Neuropsychological effects of vasopressin in healthy humans. Prog Brain Res 1998, 119:619-643.
20. Bornstein R., Baker G., Douglass A. Depression and memory in major depression disorder. J Neuropsychiatry Clin Neurosci 1991, 3:78-80.
21. Bozarth M.A. Opiate reinforcement processes: re-assembling multiple mechanisms. Addiction 1994, 89:1425-1434.
22. Brand M., Markowitsch H.J. The role of the prefrontal cortex in episodic memory. Handbook of Behavioral Neuroscience, Handbook of Episodic Memory 2008, vol. 18:317-341. Elsevier, Amsterdam.
23. Brand M., Kalbe E., Fujiwara E., Huber M., Markowitsch H.J. Cognitive estimation in patients with probable Alzheimer's disease and alcoholic Korsakoff patients. Neuropsychologia 2003, 41:575-584.
24. Braver T.S., Barch D.M., Cohen J.D. Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function. Biol Psychiatry 1999, 46:312-328.
25. Brittlebank A.D., Scott J., Williams J.M., Ferrier I.N. Autobiographical memory in depression: state or trait marker?. Br J Psychiatry 1993, 162:118-121.
26. Cahill L., McGaugh J.L. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci 1998, 21:294-299.
27. Carlezon W.A., Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56:122-132.
28. Charlton R.A., Barrick T.R., Markus H.S., Morris R.G. The relationship between episodic long-term memory and white matter integrity in normal aging. Neuropsychologia 2010, 48:114-122.
29. Conway M.A., Singer J.A., Tagini A. The self and autobiographical memory: Correspondence and coherence. Soc Cogn 2004, 22:491-529.
30. Craig A.D. How do you feel-now? The anterior insula and human awareness. Nat Rev Neurosci 2009, 10:59-70.
31. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides 1994, 15:731-755.
32. Daugé V., Léna I. CCK in anxiety and cognitive processes. Neurosci Biobehav Rev 1998, 22:815-825.
33. Davidson R.J., Lewis D., Alloy L., Amaral D., Bush G., Cohen J., et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 2002, 52:478-502.
34. de Wied D., Diamant M., Fodor M. Central nervous system effects of the neurohypophyseal hormones and related peptides. Front Neuroendocrinol 1993, 14:251-302.
35. de Wied D., Sigling H.O. Neuropeptides involved in the pathophysiology of schizophrenia and major depression. Neurotox Res 2002, 4:453-468.
36. Denecke H., Czehak N., Pietrowsky R. Dose-response relationships of intranasal cholecystokinin and the P300 event-related brain potential. Pharmacol Biochem Behav 2002, 73:593-600.
37. Denecke H., Meyer F., Feldkamp J., Fritzen R., Pietrowsky R. Repetitive intransal administration of cholecystokinin potentiates its central nervous effects. Physiol Behav 2004, 83:39-45.
38. Dere E., Huston J.P., De Souza Silva M.A. Episodic-like memory in mice: Simultaneous assessment of object, place and temporal order memory. Brain Res Brain Res Protoc 2005, 16:10-19.
39. Dere E., Kart-Teke E., Huston J.P., De Souza Silva M.A. The case for episodic memory in animals. Neurosci Biobehav Rev 2006, 30:1206-1224.
40. Dere E., Zlomuzica A., Huston J.P., De Souza Silva M.A. Animal episodic memory. Handbook of Behavioral Neuroscience, Handbook of Episodic Memory 2008, vol. 18:155-184. Elsevier, Amsterdam, [Chapter 2.2].
41. Diaz Brinton R. Vasopressin in the mammalian brain: the neurobiology of a mnemonic peptide. Prog Brain Res 1998, 119:177-199.
42. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol Rev 1999, 51:7-61.
43. Dobie D.J. Depression, dementia, and pseudodementia. Semin Clin Neuropsychiatry 2002, 7:170-186.
44. Dolan R.J. Emotion, cognition, and behavior. Science 2002, 298:1191-1194.
45. Drevets W.C. Neuroimaging abnormalities in the amygdala in mood disorders. Ann N Y Acad Sci 2003, 985:420-444.
46. Drevets W.C., Ongür D., Price J.L. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol Psychiatry 1998, 3:220-226.
47. Ebner K., Sartori S.B., Singewald N. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr Pharm Des 2009, 15:1647-1674.
48. Elzinga B.M., Bremner J.D. Are the neural substrates of memory the final common pathway in posttraumatic stress disorder (PTSD)?. J Affect Disord 2002, 70:1-17.
49. Engelmann M., Wotjak C.T., Ebner K., Landgraf R. Behavioural impact of intraseptally released vasopressin and oxytocin in rats. Exp Physiol 2000, 85:125S-130S.
50. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci Biobehav Rev 1996, 20:341-358.
51. Galluzzi S., Frisoni G.B. J Imaging, subjective complaints, and MCI: 30 years before. J Nutr Health Aging 2008, 12:80S-83S.
52. Geuze E., Vermetten E., Ruf M., de Kloet C.S., Westenberg H.G. Neural correlates of associative learning and memory in veterans with posttraumatic stress disorder. J Psychiatr Res 2008, 42:659-669.
53. Gilboa A., Winocur G., Rosenbaum R.S., Poreh A., Gao F., Black S.E., et al. Hippocampal contributions to recollection in retrograde and anterograde amnesia. Hippocampus 2006, 16:966-980.
54. Golden A.M., Dalgleish T., Mackintosh B. Levels of specificity of autobiographical memories and of biographical memories of the deceased in bereaved individuals with and without complicated grief. J. Abnorm Psychol 2007, 116:786-795.
55. Graham K.S., Lee A.C.H., Barense M.D. Memory and perceptual impairments in amnesia and dementia. Handbook of Behavioral Neuroscience, Handbook of Episodic Memory 2008, vol. 18:485-501. Elsevier, Amsterdam.
56. Grillon C. Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) 2008, 199:421-437.
57. Gualtieri C.T., Morgan D.W. The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J Clin Psychol 2008, 69:1122-1130.
58. Hebb A.L., Poulin J.F., Roach S.P., Zacharko R.M., Drolet G. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:1225-1238.
59. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci 1998, 1:318-323.
60. Hermans D., de Decker A., de Peuter S., Raes F., Eelen P., Williams J.M. Autobiographical memory specificity and affect regulation: coping with a negative life event. Depress Anxiety 2008, 25:787-792.
61. Herranz R. Cholecystokinin antagonists: pharmacological and therapeutic potential. Med Res Rev 2003, 23:559-605.
62. Höschl C., Hajek T. Hippocampal damage mediated by corticosteroids-a neuropsychiatric research challenge. Eur Arch Psychiatry Clin Neurosci 2001, 251:II81-II88.
63. Isaac C.L., Cushway D., Jones G.V. Is posttraumatic stress disorder associated with specific deficits in episodic memory?. Clin Psychol Rev 2006, 26:939-955.
64. Izquierdo I., Vianna M.R., Izquierdo L.A., Barros D.M., Szapiro G., Coitinho A.S., et al. Memory retrieval and its lasting consequences. Neurotox Res 2002, 4:573-593.
65. Jessen F., Scheef L., Germeshausen L., Tawo Y., Kockler M., Kuhn K.U., et al. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry 2003, 160:1305-1312.
66. Joseph R. Traumatic amnesia, repression, and hippocampus injury due to emotional stress, corticosteroids and enkephalins. Child Psychiatry Hum Dev 1998, 29:169-185.
67. Kalueff A.V. Neurobiology of memory and anxiety: from genes to behavior. Neural Plast 2007, 78171.
68. Kart-Teke E., De Souza Silva M.A., Huston J.P., Dere E. Wistar rats show episodic-like memory for unique experiences. Neurobiol Learn Mem 2006, 85:173-182.
69. Kart-Teke E., Dere E., Brandao M., Huston J.P., De Souza Silva M.A. Reinstatement of episodic-like memory in rats by NK-1 receptor antagonism. Neurobiol Learn Mem 2007, 87:324-331.
70. Kensinger E.A. How emotion affects older adults' memories for event details. Memory 2009, 17:208-219.
71. Kensinger E.A., Corkin S. Two routes to emotional memory: distinct neural processes for valence and arousal. Proc Natl Acad Sci USA 2004, 101:3310-3315.
72. Kensinger E.A., Schacter D.L. Remembering the specific visual details of presented objects: neuroimaging evidence for effects of emotion. Neuropsychologia 2007, 45:2951-2962.
73. Kesner R.P., Hunsaker M.R. The temporal attributes of episodic memory. Behav Brain Res 2010, 215:299-309.
74. Kleim B., Ehlers A. Reduced autobiographical memory specificity predicts depression and posttraumatic stress disorder after recent trauma. J Consult Clin Psychol 2008, 76:231-242.
75. Kopelman M.D., Wilson B.A., Baddeley A.D. The autobiographical memory interview: a new assessment of autobiographical and personal semantic memory in amnesic patients. J Clin Exp Neuropsychol 1989, 11:724-744.
76. Layton B., Krikorian R. Memory mechanisms in posttraumatic stress disorder. J Neuropsychiatry Clin Neurosci 2002, 14:254-261.
77. LeDoux J. The amygdala. Curr Biol 2007, 17:R868-R874.
78. Lehtovirta M., Laakso M.P., Soininen H., Helisalmi S., Mannermaa A., Helkala E.L., et al. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995, 67:65-72.
79. Levens S.M., Gotlib I.H. Impaired selection of relevant positive information in depression. Depress Anxiety 2009, 26:403-410.
80. Levenson R.W., Carstensen L.L., Friesen W.V., Ekman P. Emotion, physiology, and expression in old age. Psychol Aging 1991, 6:28-35.
81. Lindauer R.J., Olff M., van Meijel E.P., Carlier I.V., Gersons B.P. Cortisol, learning, memory, and attention in relation to smaller hippocampal volume in police officers with posttraumatic stress disorder. Biol Psychiatry 2006, 59:171-177.
82. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989, 9:258-279.
83. Mariani E., Monastero R., Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007, 12:23-35.
84. Marinelli S., Pascucci T., Bernardi G., Puglisi-Allegra S., Mercuri N.B. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 2005, 30:864-870.
85. Markowitsch H.J., Calabrese P., Würker M., Durwen H.F., Kessler J., Babinsky R., et al. The amygdala's contribution to memory-a study on two patients with Urbach-Wiethe disease. Neuroreport 1994, 5:1349-1352.
86. Markowitsch H.J., Thiel A., Reinkemeier M., Kessler J., Koyuncu A., Heiss W.D. Right amygdalar and temporofrontal activation during autobiographic, but not during fictitious memory retrieval. Behav Neurol 2000, 12:181-190.
87. Mathews J., Barch D. Episodic memory for emotional and non-emotional words in individuals with anhedonia. Psychiatry Res 2006, 143:121-133.
88. McEwen B.B. Closing remarks: review and commentary on selected aspects of the roles of vasopressin and oxytocin in memory processing. Adv Pharmacol 2004, 50:593-708.
89. McGaugh J.L. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004, 27:1-28.
90. McGaugh J.L. Make mild moments memorable: add a little arousal. Trends Cogn Sci 2006, 10:345-347.
91. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci USA 1996, 93:13508-13514.
92. McIntyre C.K., Power A.E., Roozendaal B., McGaugh J.L. Role of the basolateral amygdala in memory consolidation. Ann N Y Acad Sci 2003, 985:273-293.
93. McLean S. Do substance P and the NK1 receptor have a role in depression and anxiety?. Curr Pharm Des 2005, 11:1529-1547.
94. Meisenzahl E.M., Koutsouleris N., Bottlender R., Scheuerecker J., Jäger M., Teipel S.J., et al. Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res 2008, 104:44-60.
95. Mervaala E., Föhr J., Könönen M., Valkonen-Korhonen M., Vainio P., Partanen K., et al. Quantitative MRI of the hippocampus and amygdala in severe depression. Psychol Med 2000, 30:117-125.
96. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
97. Mizuno K., Wakai M., Takeda A., Sobue G. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. J Neurol Sci 2000, 173:18-24.
98. Montoya A., Lal S., Menear M., Duplessis E., Thavundayil J., Schmitz N., et al. Apomorphine effects on episodic memory in young healthy volunteers. Neuropsychologia 2008, 46:292-300.
99. Moradi A.R., Herlihy J., Yasseri G., Shahraray M., Turner S., Dalgleish T. Specificity of episodic and semantic aspects of autobiographical memory in relation to symptoms of posttraumatic stress disorder (PTSD). Acta Psychol (Amst) 2008, 127:645-653.
100. Morris R.G. Elements of a neurobiological theory of hippocampal function: the role of synaptic plasticity, synaptic tagging and schemas. Eur J Neurosci 2006, 23:2829-2846.
101. Mosconi L., Brys M., Glodzik-Sobanska L., De Santi S., Rusinek H., de Leon M.J. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol 2007, 42:129-138.
102. Murray E.A. The amygdala, reward and emotion. Trends Cogn Sci 2007, 11:489-497.
103. Noël A., Quinette P., Guillery-Girard B., Dayan J., Piolino P., Marquis S., et al. Psychopathological factors, memory disorders and transient global amnesia. Br J Psychiatry 2008, 193:145-151.
104. Norrholm S.D., Ressler K.J. Genetics of anxiety and trauma-related disorders. Neuroscience 2009, 164:272-287.
105. Ouldred E., Bryant C. Dementia care. Part 1: guidance and the assessment process. Br J Nurs 2008, 17:138-1145.
106. Packard M.G. Anxiety, cognition, and habit: A multiple memory systems perspective. Brain Res 2009, 1293:121-128.
107. Packard M.G., Cahill L. Affective modulation of multiple memory systems. Curr Opin Neurobiol 2001, 11:752-756.
108. Paré D. Role of the basolateral amygdala in memory consolidation. Prog Neurobiol 2003, 70:409-420.
109. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
110. Paulus M.P., Stein M.B. An insular view of anxiety. Biol Psychiatry 2006, 60:383-387.
111. Pause B.M., Hellmann G., Göder R., Aldenhoff J.B., Ferstl R. Increased processing speed for emotionally negative odors in schizophrenia. Int J Psychophysiol 2008, 70:16-22.
112. Pause B, Jungbluth C, Adolph D, Pietrowsky R, Dere E. Induction and measurement of episodic memories in healthy adults; in press.
113. Pause B.M., Krauel K. Chemosensory event-related potentials (CSERP) as a key to the psychology of odors. Int J Psychophysiol 2000, 36:105-122.
114. Pause B.M., Raack N., Sojka B., Göder R., Aldenhoff J.B., Ferstl R. Convergent and divergent effects of odors and emotions in depression. Psychophysiology 2003, 40:209-225.
115. Payne J.D., Jackson E.D., Hoscheidt S., Ryan L., Jacobs W.J., Nadel L. Stress administered prior to encoding impairs neutral but enhances emotional long-term episodic memories. Learn Mem 2007, 14:861-868.
116. Perlstein W.M., Dixit N.K., Carter C.S., Noll D.C., Cohen J.D. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 2003, 53:25-38.
117. Perras B., Droste C., Born J., Fehm H.L., Pietrowsky R. Verbal memory after three months of intranasal vasopressin in healthy old humans. Psychoneuroendocrinology 1997, 22:387-396.
118. Phelps E.A., Labar K.S., Anderson A.K., O'connor K.J., Fulbright R.K., Spencer D.D. Specifying the contributions of the human amygdala to emotional memory: a case study. Neurocase 1998, 6:527-540.
119. Potter G.G., Steffens D.C. Contribution of depression to cognitive impairment and dementia in older adults. Neurologist 2007, 13:105-117.
120. Preuschoff K., Quartz S.R., Bossaerts P. Human insula activation reflects risk prediction errors as well as risk. J Neurosci 2008, 28:2745-2752.
121. Raes F., Hermans D., de Decker A., Eelen P., Williams J.M. Autobiographical memory specificity and affect regulation: an experimental approach. Emotion 2003, 3:201-206.
122. Ranganath C., Minzenberg M.J., Ragland J.D. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry 2008, 64:18-25.
123. Riepe M.W. Cholinergic treatment: what are the early neuropathological targets?. Eur J Neurol 2005, 12:3-9.
124. Ringman J.M. What the study of persons at risk for familial Alzheimer's disease can tell us about the earliest stages of the disorder: a review. J Geriatr Psychiatry Neurol 2005, 18:228-233.
125. Roberts W.A. Are animals stuck in time?. Psychol Bull 2002, 128:473-489.
126. Roozendaal B., McEwen B.S., Chattarji S. Stress, memory and the amygdala. Nat Rev Neurosci 2009, 10:423-433.
127. Rubin D.C., Berntsen D., Bohni M.K. A memory-based model of posttraumatic stress disorder: evaluating basic assumptions underlying the PTSD diagnosis. Psychol Rev 2008, 115:985-1011.
128. Rupniak N.M., Carlson E.J., Webb J.K., Harrison T., Porsolt R.D., Roux S., et al. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs. Behav Pharmacol 2001, 12:497-508.
129. Sarazin M., Dubois B. A guide to diagnosis of Alzheimer's disease. Rev Prat 2005, 55:1879-1890.
130. Sarnyai Z. Oxytocin and neuroadaptation to cocaine. Prog Brain Res 1998, 119:449-466.
131. Saxena S., Brody A.L., Ho M.L., Alborzian S., Ho M.K., Maidment K.M., et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently. Biol Psychiatry 2001, 50:159-170.
132. Schneider R., Osterburg J., Buchner A., Pietrowsky R. Effect of intranasally administered cholecystokinin on encoding of controlled and automatic memory processes. Psychopharmacology (Berl) 2009, 202:559-567.
133. Schneider R., Stöhr C., Pietrowsky R. Intranasally administered cholecystokinin decreases controlled memory. Biol Psychol 2005, 69:297-314.
134. Schott B.H., Minuzzi L., Krebs R.M., Elmenhorst D., Lang M., Winz O.H., et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 2008, 28:14311-14319.
135. Schott B.H., Seidenbecher C.I., Fenker D.B., Lauer C.J., Bunzeck N., Bernstein H.G., et al. The dopaminergic midbrain participates in human episodic memory formation: evidence from genetic imaging. J Neurosci 2006, 26:1407-1417.
136. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., Erspamer V. The tachykinin peptide family. Pharmacol Rev 2002, 54:285-322.
137. Shin L.M., Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010, 35:169-191.
138. Shin L.M., Rauch S.L., Pitman R.K. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 2006, 1071:67-79.
139. Siebert M., Markowitsch H.J., Bartel P. Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 2003, 126:2627-2637.
140. Singer J.A. Seeing one's self: locating narrative memory in a framework of personality. J Pers 1995, 63:429-457.
141. St Jacques P.L., Dolcos F., Cabeza R. Effects of aging on functional connectivity of the amygdala for subsequent memory of negative pictures: a network analysis of functional magnetic resonance imaging data. Psychol Sci 2009, 20:74-84.
142. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 1999, 46:1480-1508.
143. Strange B.A., Dolan R.J. Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci USA 2004, 101:11454-11458.
144. Strupp B.J., Levitsky D.A. A mnemonic role for vasopressin: the evidence for and against. Neurosci Biobehav Rev 1985, 9:399-411.
145. Sutherland K., Bryant R.A. Autobiographical memory in posttraumatic stress disorder before and after treatment. Behav Res Ther 2007, 45:2915-2923.
146. Takahashi Y.K., Roesch M.R., Stalnaker T.A., Haney R.Z., Calu D.J., Taylor A.R., et al. The orbitofrontal cortex and ventral tegmental area are necessary for learning from unexpected outcomes. Neuron 2009, 62:269-280.
147. Teyler T.J., Rudy J.W. The hippocampal indexing theory and episodic memory: updating the index. Hippocampus 2007, 17:1158-1169.
148. Thomas-Anterion C., Laurent B. Les marqueurs neuropsychologiques du diagnostic de la maladie d'Alzheimer. Rev Neurol (Paris) 2006, 162:913-920.
149. Titone D., Ditman T., Holzman P.S., Eichenbaum H., Levy D.L. Transitive inference in schizophrenia: impairments in relational memory organization. Schizophr Res 2004, 68:235-247.
150. Tsoory M.M., Vouimba R.M., Akirav I., Kavushansky A., Avital A., Richter-Levin G. Amygdala modulation of memory-related processes in the hippocampus: potential relevance to PTSD. Prog Brain Res 2008, 167:35-51.
151. Tulving E. Elements of episodic memory 1983, Clarendon Press, Oxford.
152. Tulving E. Episodic memory: from mind to brain. Ann Rev Psychol 2002, 53:1-25.
153. Tulving E., Markowitsch H.J. Episodic and declarative memory: role of the hippocampus. Hippocampus 1998, 8:198-204.
154. Van Ree J.M., Hijman R., Jolles J., De Wied D. Vasopressin and related peptides: animal and human studies. Prog Neuropsychopharmacol Biol Psychiatry 1985, 9:551-559.
155. Vermetten E., Schmahl C., Lindner S., Loewenstein R.J., Bremner J.D. Hippocampal and amygdalar volumes in dissociative identity disorder. Am J Psychiatry 2006, 163:630-636.
156. Weniger G., Lange C., Irle E. Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. J Affect Disord 2006, 94:219-229.
157. Wettstein J.G., Buéno L., Junien J.L. CCK antagonists: pharmacology and therapeutic interest. Pharmacol Ther 1994, 62:267-282.
158. Whalley M.G., Rugg M.D., Smith A.P., Dolan R.J., Brewin C.R. Incidental retrieval of emotional contexts in post-traumatic stress disorder and depression: an fMRI study. Brain Cogn 2009, 69:98-107.
159. Wiest G., Lehner-Baumgartner E., Baumgartner C. Panic attacks in an individual with bilateral selective lesions of the amygdala. Arch Neurol 2006, 63:1798-1801.
160. Williams J.M., Barnhofer T., Crane C., Herman D., Raes F., Watkins E., et al. Autobiographical memory specificity and emotional disorder. Psychol Bull 2007, 133:122-148.
161. Williams J.M., Broadbent K. Autobiographical memory in suicide attempters. J Abnorm Psychol 1986, 95:144-149.
162. Williams A.D., Moulds M.L. Negative appraisals and cognitive avoidance of intrusive memories in depression: a replication and extension. Depress Anxiety 2008, 25:E26-33.
163. Wise R.A. Drug-activation of brain reward pathways. Drug Alcohol Depend 1998, 51:13-22.
164. Wise R.A. Brain reward circuitry: insights from unsensed incentives. Neuron 2002, 36:229-240.
165. Wise R.A. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008, 14:169-183.
166. Wittmann B.C., Schott B.H., Guderian S., Frey J.U., Heinze H.J., Düzel E. Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 2005, 45:459-467.
167. Wright S.L., Persad C. Distinguishing between depression and dementia in older persons: neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol 2007, 20:189-198.
168. Yehuda R., Harvey P.D., Buchsbaum M., Tischler L., Schmeidler J. Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. Neuropsychopharmacology 2007, 32:2581-2591.
169. Zeijlmans van Emmichoven I.A., van IJzendoorn M.H., de Ruiter C., Brosschot J.F. Selective processing of threatening information: effects of attachment representation and anxiety disorder on attention and memory. Dev Psychopathol 2003, 15:219-237.
170. Zlomuzica A., Dere E., Huston J.P., De Souza Silva M.A. The selective NK3 receptor agonist senktide promotes episodic-like memory in mice. Neurobiol Learn Mem 2008, 90:420-425.
171. Zlomuzica A., De Souza Silva M.A., Huston J.P., Dere E. NMDA receptor modulation by d-cycloserine promotes episodic-like memory in mice. Psychopharmacology (Berl) 2007, 193:503-509.